Enhanced vasodilation to endothelin antagonism in patients with compensated cirrhosis and the role of nitric oxide

Helmy, A.; Newby, D.E.; Jalan, R.; Hayes, P.C.; Webb, D.J.
March 2003
Gut;Mar2003, Vol. 52 Issue 3, p410
Academic Journal
Background and aims: Patients with advanced cirrhosis have systemic vasodilatation and increased nitric oxide (NO) production despite activated vasopressor systems, including the endothelin system. The aims of this study were to assess the contribution of endogenous endothelin 1 (ET-1) and NO to the maintenance of basal forearm vascular tone in patients with preascitic cirrhosis (n=7) and in age and sex matched healthy controls (n=7). Methods: Using venous occlusion plethysmography, forearm blood flow (FBF) responses to subsystemic locally active intra-arterial infusion of BQ-123 (a selective endothelin type A receptor (ET[sub A]) receptor antagonist; 10 nmol/min) were measured before and during application of an "NO clamp": a balanced co- infusion of L-N[sub G]-monomethyl-arginine (a selective NO synthase inhibitor) and sodium nitroprusside (an exogenous NO donor) to block endogenous NO production and restore NO mediated basal FBF, respectively. Results: L-NMMA infusion produced a reduction in FBF (p<0.001) which was similar in both groups. Before applying the "NO clamp", BQ-123 caused an increase in FBF in both groups (p<0.001) that was greater in patients with cirrhosis (p<0.01). During the "NO clamp", BQ-123 induced vasodilatation was abolished in controls and attenuated in patients (p<0.001) but remained significantly greater in patients with cirrhosis (p<0.01). Conclusions: These findings indicate a greater ETA mediated contribution of endogenous ET-1 to the maintenance of basal forearm vascular tone in patients with preascitic cirrhosis. In addition, enhanced vasodilatation to ET[sub A] receptor antagonism in cirrhosis cannot be entirely attributed to NO release but is likely to be related to reversal of direct ET-1 mediated tone.


Related Articles

  • Endothelin-1: The Yin and Yang on Vascular Function. Marasciulo, Flora Linda; Montagnani, Monica; Potenza, Maria Assunta // Current Medicinal Chemistry;2006, Vol. 13 Issue 14, p1655 

    Endothelin-1 (ET-1) is a vasoconstrictor secreted by endothelial cells, which acts as the natural counterpart of the vasodilator nitric oxide (NO). ET-1 contributes to vascular tone and regulates cell proliferation through activation of ETA and ETB receptors. Physical factors such as shear...

  • Physiological concentrations of insulin induce endothelin-mediated vasoconstriction during inhibition of NOS or PI3-kinase in skeletal muscle arterioles. Eringa, Etto C.; Stehouwer, Coen D.A.; Merlijn, Thomas; Westerhof, Nico; Sipkema, Pieter // Cardiovascular Research;Dec2002, Vol. 56 Issue 3, p464 

    Objective: To determine the roles of nitric oxide, endothelin-1 and phosphatidylinositol 3-kinase (PI3-kinase) in acute responses of isolated rat skeletal muscle arterioles to insulin. Methods: Rat cremaster first order arterioles were separated from surrounding tissue, cannulated...

  • Chronic ETA receptor blockade prevents endothelial dysfunction of small arteries in apolipoprotein E-deficient mice. d’Uscio, Livius V.; Barton, Matthias; Shaw, Sidney; Lüscher, Thomas F. // Cardiovascular Research;Feb2002, Vol. 53 Issue 2, p487 

    Objective: This study investigated whether endothelial dysfunction occurs in mesenteric arteries of apoE-deficient mice and determined the role of endothelin (ET)-1, which is increased in human atherosclerosis, using an orally active endothelin ETA receptor antagonist. Methods:...

  • Exposure of endothelial cells to recombinant human erythropoietin induces nitric oxide synthase activity. Banerjee, Debendranath; Rodriguez, Marilis; Nag, Mihir; Adamson, John W. // Kidney International;May2000, Vol. 57 Issue 5, p1895 

    Exposure of endothelial cells to recombinant human erythropoietin induces nitric oxide synthase activity. Background. Anemic patients with chronic renal failure receiving recombinant human erythropoietin (rHuEPO) therapy frequently develop hypertension through an unknown mechanism. We...

  • Old-timer makes a comeback. Vanhoutte, Paul M. // Nature;11/19/1998, Vol. 396 Issue 6708, p213 

    Discusses the role of endothelium-derived hyperpolarizing factor (EHDF) to certain endothelium-dependent relaxations. Suggestion of the identity for, and antagonists against EHDF; Role of potassium ions in hyperpolarization.

  • Role of endothelin and nitric oxide imbalance in the pathogenesis of hypoxia-induced arterial hypertension. Zhenmin Ni; Bemanian, Shahrooz; Kivlighn, Salah D.; Vaziri, Nosratola D. // Kidney International;Jul1998, Vol. 54 Issue 1, p188 

    Examines the role of endothelin and nitric oxide imbalance in the pathogenesis of hypoxia-induced arterial hypertension. Inhibition of nitric oxide by endothelial cells; Exhibition of plasma endothelin; Influence of nitric oxide in normal blood pressure.

  • Significance of Plasma Nitric Oxicle/Endothelial-1 Ratio for Prediction of Coronary Artery Disease. Kurita, Akira; Matsui, Takemi; Ishizuka, Toshiaki; Takase, Bonpei; Satomura, Kimio // Angiology;May/Jun2005, Vol. 56 Issue 3, p259 

    Vascular tone is regulated by vasodilators and vasoconstrictors. Endothelin-1 (ET-1) is the predominant vasoconstrictor peptide that constricts vascular smooth muscle, whereas nitric oxide (NO) is the primary vasodilator peptide that relaxes vascular smooth muscle. In this study, the authors...

  • Interactions between endothelin and nitric oxide in the regulation of vascular tone in obesity and diabetes. Mather, Kieren J.; Lteif, Amale; Steinberg, Helmut O.; Baron, Alain D. // Diabetes;Aug2004, Vol. 53 Issue 8, p2060 

    Endothelial dysfunction reflects an imbalance of vasodilators and vasoconstrictors. Endogenous endothelin activity seems to be increased in human obesity and type 2 diabetes, and cellular studies suggest that this factor may itself reduce bioavailable nitric oxide (NO). We studied 20 lean, 20...

  • The state of the guanylate cyclase mechanism of vasodilatation before and after thyroidectomy in the patients presenting with toxic goiter. ILYICHEVA, E. A.; TARNUEVA, I. F.; PIVOVAROV, YU. I.; KORYAKINA, L. B.; CHIZHOVA, E. A. // Problemy Endokrinologii;2014, Vol. 60 Issue 3, p15 

    The state of the guanylate cyclase activity of myocytes was evaluated from the increment in the diameter of the brachial artery in response to the exogenous administration of nitroglycerin (#D^NO) in 64 samples obtained from 44 patients. A total of 23 studies were carried out during...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics